Chester County News and Community Website
PHILADELPHIA, PA — Authorities in Philadelphia are asking for the public’s assistance in identifying a suspect and vehicle involved in an alleged hit-and-run incident that left a woman seriously injured.
Driver Sought in Shocking Hit-and-Run That Left Woman Critically Injured Read More
MALVERN, PA — YPrime has announced that Dr. Karl McEvoy, Vice President of eCOA and Patient Technologies, has been appointed Industry Co-Director of the Critical Path Institute’s eCOA Consortium for 2025.
YPrime’s Dr. Karl McEvoy Named Co-Director of eCOA Consortium Read More
PHILADELPHIA, PA — The Philadelphia Police Department is asking for the public’s help in identifying a suspect involved in an alleged attempted robbery near 1200 Filbert Street on January 14, …
Police Hunt for Suspect in Bold Philadelphia Robbery Attempt Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has been granted a U.S. patent for the use of its leading compound, buntanetap, in the treatment and prevention of acute brain and …
Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap Read More
WILMINGTON, DE — A Wilmington man has been arrested in connection with an alleged armed robbery that occurred late last year, authorities announced.
Manhunt Ends: Wilmington Suspect Nabbed for Triple Armed Robbery Allegations Read More
WILMINGTON, DE — Wilmington police have arrested three individuals following an investigation into alleged illegal drug sales in the city’s West Street area.
Drug Bust in Wilmington Uncovers Stash of Narcotics and Arrests Three Suspects Read More
KENNETT SQUARE, PA — A traffic stop in Kennett Square led to the arrest of a Delaware man wanted on an outstanding warrant, police said.
Delaware Man Arrested in Kennett Square on Outstanding Warrant Read More
PHILADELPHIA, PA — Proscia® has reported record-breaking growth in 2024, more than doubling its business and solidifying its position as a leader in enterprise pathology. The company now enters 2025 with …
Proscia Doubles Growth in 2024, Sets Sights on Advancing Precision Medicine in 2025 Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has shared its preliminary fourth quarter and full-year revenue figures for 2024, alongside robust guidance and strategic priorities for 2025. The report highlights …
Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has revealed significant progress in its pipeline and operations, underscoring its focus on advancing rese-cel, a cell therapy candidate for autoimmune diseases. …
Cabaletta Bio Advances Autoimmune Therapy, Sets Strategic Goals for 2025 Read More